1. Home
  2. ABOS vs CAAS Comparison

ABOS vs CAAS Comparison

Compare ABOS & CAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABOS
  • CAAS
  • Stock Information
  • Founded
  • ABOS 1996
  • CAAS N/A
  • Country
  • ABOS United States
  • CAAS China
  • Employees
  • ABOS N/A
  • CAAS N/A
  • Industry
  • ABOS Biotechnology: Pharmaceutical Preparations
  • CAAS Auto Parts:O.E.M.
  • Sector
  • ABOS Health Care
  • CAAS Consumer Discretionary
  • Exchange
  • ABOS Nasdaq
  • CAAS Nasdaq
  • Market Cap
  • ABOS 109.6M
  • CAAS 129.7M
  • IPO Year
  • ABOS 2021
  • CAAS N/A
  • Fundamental
  • Price
  • ABOS $1.55
  • CAAS $4.08
  • Analyst Decision
  • ABOS Strong Buy
  • CAAS
  • Analyst Count
  • ABOS 3
  • CAAS 0
  • Target Price
  • ABOS $8.00
  • CAAS N/A
  • AVG Volume (30 Days)
  • ABOS 275.1K
  • CAAS 59.6K
  • Earning Date
  • ABOS 11-12-2025
  • CAAS 11-12-2025
  • Dividend Yield
  • ABOS N/A
  • CAAS N/A
  • EPS Growth
  • ABOS N/A
  • CAAS 5.68
  • EPS
  • ABOS N/A
  • CAAS 1.11
  • Revenue
  • ABOS N/A
  • CAAS $725,260,000.00
  • Revenue This Year
  • ABOS N/A
  • CAAS N/A
  • Revenue Next Year
  • ABOS N/A
  • CAAS N/A
  • P/E Ratio
  • ABOS N/A
  • CAAS $3.87
  • Revenue Growth
  • ABOS N/A
  • CAAS 16.72
  • 52 Week Low
  • ABOS $0.86
  • CAAS $3.50
  • 52 Week High
  • ABOS $2.66
  • CAAS $5.37
  • Technical
  • Relative Strength Index (RSI)
  • ABOS 35.12
  • CAAS 39.04
  • Support Level
  • ABOS $1.74
  • CAAS $4.04
  • Resistance Level
  • ABOS $2.04
  • CAAS $4.55
  • Average True Range (ATR)
  • ABOS 0.16
  • CAAS 0.18
  • MACD
  • ABOS -0.07
  • CAAS -0.00
  • Stochastic Oscillator
  • ABOS 9.20
  • CAAS 18.18

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

About CAAS China Automotive Systems Inc.

China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: